AL-RABEEAH OPENS PREVENTIVE DENTAL MEDICINE PROJECT

Read More

Despite Nation's Dramatic Increase in Spending, Little Improvement Seen in Patients

Read More

Learn to Recognize Symptoms: Mood Swings, Extreme Highs and Lows

Read More

Qnasl Nasal Aerosol Corticosteroid Avoids Drippy Feel of Wet Sprays

Read More

A new fertility technique that has increased success rates by 50 per cent allows parents to watch their baby from the moment of conception.

A sophisticated new microscope makes it possible for fertility doctors to monitor the developing fertilised egg continuously for up to five days.

It means any abnormal changes can be spotted and the egg discarded so only the best quality ones with the best chance of creating a healthy pregnancy are transferred to the womb.

Read More

Landmark British Study that Could Revolutionise Breast Cancer Treatment: It Turns Out it's Actually TEN Different Diseases

Breast cancer is effectively ten different diseases, according to breakthrough research that could revolutionise treatment.

The biggest study of its kind in the world has classified the country’s most common cancer into ten separate types.

The finding brings doctors closer to the holy grail of tailoring treatments to individual women. The rewriting of the rule book on breast cancer could also lead to new drugs and better diagnostic tests.

Read More

Vaccines against heart disease could be available within five years, a London conference has heard.

Injections of antibodies could prevent the build up of fat in the arteries which cause narrowings and break off leading to heart attacks, experts said.

It would be the first time that the underlying causes of heart disease was targeted instead of reducing factors such as high levels of bad cholesterol and blood pressure which increase the likelihood of heart disease developing.

Read More

Bone Density at Age 67 May Predict Later Bone Health

Read More

Infection Rates Among Men About Three Times Higher Than Among Women, Study Finds

Read More

Drug Is a New Option for AMD, a Common Cause of Blindness

The FDA has approved Eylea for the treatment of the wet form of age related macular degeneration (AMD), the major cause of blindness in the elderly.

Eylea inhibits a factor that makes unwanted blood vessels grow in the retina. The blood vessels can leak blood and fluid, causing damage to the retina. Eylea blocks all forms of this factor, called VEGF, and also blocks a second similar factor.

In June 2011, an FDA advisory panel unanimously recommended approval of Eylea, previously called VEGF Trap-Eye. The generic name for Eylea is aflibercept.

Read More